» Articles » PMID: 14769913

Incipient Alzheimer's Disease: Microarray Correlation Analyses Reveal Major Transcriptional and Tumor Suppressor Responses

Overview
Specialty Science
Date 2004 Feb 11
PMID 14769913
Citations 499
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenesis of incipient Alzheimer's disease (AD) has been resistant to analysis because of the complexity of AD and the overlap of its early-stage markers with normal aging. Gene microarrays provide new tools for addressing complexity because they allow overviews of the simultaneous activity of multiple cellular pathways. However, microarray data interpretation is often hindered by low statistical power, high false positives or false negatives, and by uncertain relevance to functional endpoints. Here, we analyzed hippocampal gene expression of nine control and 22 AD subjects of varying severity on 31 separate microarrays. We then tested the correlation of each gene's expression with MiniMental Status Examination (MMSE) and neurofibrillary tangle (NFT) scores across all 31 subjects regardless of diagnosis. These well powered tests revealed a major transcriptional response comprising thousands of genes significantly correlated with AD markers. Several hundred of these genes were also correlated with AD markers across only control and incipient AD subjects (MMSE > 20). Biological process categories associated with incipient AD-correlated genes were identified statistically (ease program) and revealed up-regulation of many transcription factor/signaling genes regulating proliferation and differentiation, including tumor suppressors, oligodendrocyte growth factors, and protein kinase A modulators. In addition, up-regulation of adhesion, apoptosis, lipid metabolism, and initial inflammation processes occurred, and down-regulation of protein folding/metabolism/transport and some energy metabolism and signaling pathways took place. These findings suggest a new model of AD pathogenesis in which a genomically orchestrated up-regulation of tumor suppressor-mediated differentiation and involution processes induces the spread of pathology along myelinated axons.

Citing Articles

Role of FPR2 antagonism in alleviating social isolation-induced depression and protecting blood-brain barrier integrity.

Zheng J, Wang H, Wu W, Wang L, Qin M, Zhu L J Neuroinflammation. 2025; 22(1):79.

PMID: 40083006 PMC: 11907847. DOI: 10.1186/s12974-025-03408-4.


Advancing Alzheimer's Therapy: Computational strategies and treatment innovations.

Paul J, Malik A, Azmal M, Gulzar T, Afghan M, Talukder O IBRO Neurosci Rep. 2025; 18:270-282.

PMID: 39995567 PMC: 11849200. DOI: 10.1016/j.ibneur.2025.02.002.


Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease.

Coleman P, Delvaux E, Kordower J, Boehringer A, Huseby C Alzheimers Dement. 2025; 21(2):e14555.

PMID: 39912452 PMC: 11851168. DOI: 10.1002/alz.14555.


Brain Transcriptome Changes Associated With an Acute Increase of Protein O-GlcNAcylation and Implications for Neurodegenerative Disease.

Bell M, Kane M, Ouyang X, Young M, Jegga A, Chatham J J Neurochem. 2025; 169(1):e16302.

PMID: 39823370 PMC: 11741514. DOI: 10.1111/jnc.16302.


The lemur tail kinase family in neuronal function and disfunction in neurodegenerative diseases.

Larose A, Miller C, Morotz G Cell Mol Life Sci. 2024; 81(1):447.

PMID: 39520508 PMC: 11550312. DOI: 10.1007/s00018-024-05480-0.


References
1.
Loring J, Wen X, Lee J, Seilhamer J, Somogyi R . A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2002; 20(11):683-95. DOI: 10.1089/10445490152717541. View

2.
Campisi J . Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001; 11(11):S27-31. DOI: 10.1016/s0962-8924(01)02151-1. View

3.
Lipinski M, Macleod K, Williams B, Mullaney T, Crowley D, Jacks T . Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system. EMBO J. 2001; 20(13):3402-13. PMC: 125524. DOI: 10.1093/emboj/20.13.3402. View

4.
Miller R, Galecki A . Interpretation, design, and analysis of gene array expression experiments. J Gerontol A Biol Sci Med Sci. 2001; 56(2):B52-7. DOI: 10.1093/gerona/56.2.b52. View

5.
Mucke L, Masliah E, Yu G, Mallory M, Rockenstein E, Tatsuno G . High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000; 20(11):4050-8. PMC: 6772621. View